Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC 62935-753-75, Manufactured by: Tolmar Inc., Fort Collins, CO 80526, For Tolmar Therapeutics Inc., Fort Collins, CO 80526.
Published October 4, 2023 · Recall initiated: September 12, 2023
Summary
FDA records drug Class III recall D-1178-2023, published October 4, 2023 and initiated September 12, 2023. Recalling firm: Tolmar, Inc.; Status: Terminated; Reported quantity: 2990 cartons; Lot: Lot: 13635A1, Exp. 07/31/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
What to do
Voluntary: Firm initiated · Letter
Get an email if ELIGARD has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ELIGARD
- Manufacturer
- Tolmar, Inc.
- Distributor
- Nationwide in the US.
- Lot
- Lot: 13635A1, Exp. 07/31/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFlorbetaben F-18 (Neuraceq®) Injection Solution 1.4 to 135 mCi/mL, 50 mL in 1 multi-dose glass vial,October 4, 2023
- FDAClearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, furtherOctober 4, 2023
- FDACerebelly Smart Bar; Apple Kale flavor; 5 pk and 7 pk; ambient storageOctober 4, 2023
- FDACerebelly Smart Bar; Blueberry Banana flavor; 5 pk; ambient storageOctober 4, 2023
- FDAPerifix® / Epidural anesthesia set, medicatedSeptember 27, 2023
- FDAGallant VR Implantable Cardioverter Defibrillator: VR ICD REF CDVRA500Q Gallant DR Implantable CardioverterSeptember 27, 2023
Questions about this recall
Was Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC 62935-753-75, Manufactured by: Tolmar Inc., Fort Collins, CO 80526, For Tolmar Therapeutics Inc., Fort Collins, CO 80526. recalled?
Yes. FDA published recall D-1178-2023 on October 4, 2023. Reported hazard: Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ELIGARD.